Renaissance Capital logo

IPO News & Commentary

Get the latest insights on new stocks

Allergy and autoimmune biotech Lycia Therapeutics sets terms for $250 million IPO

Lycia Therapeutics logo

Lycia Therapeutics, a Phase 1 biotech developing protein degraders for food allergy and Graves' disease, announced terms for its IPO on Tuesday. The South San Francisco, CA-based company plans to raise $250 million by offering 14.7 million shares at a price...read more

Space systems developer Gravitics Holdings slashes share offering by 60% ahead of $50 million IPO

Gravitics Holdings logo

Gravitics Holdings, which develops space structures and orbital systems, lowered the proposed deal size for its upcoming IPO on Tuesday. The Miami, FL-based company now plans to raise $50 million by offering 3.2 million shares at a price range of $14 to $17....read more

UK-based nursery operator iStep Learning files for a $18 million US IPO

iStep Learning logo

iStep Learning, which operates nurseries in the UK, filed on Monday with the SEC to raise up to $18 million in an initial public offering. The company plans to raise $18 million by offering 4 million shares at a price range of $4 to $5. At the midpoint of the ...read more

IPO News By Industry

Be the in-house IPO Expert

Our clients are focused on catalyzing growth and creating value.

Not scouring the web for IPO data.

Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.